349 related articles for article (PubMed ID: 30033780)
1. Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery.
Vllasaliu D; Thanou M; Stolnik S; Fowler R
Expert Opin Drug Deliv; 2018 Aug; 15(8):759-770. PubMed ID: 30033780
[TBL] [Abstract][Full Text] [Related]
2. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease.
Zhang Y; Thanou M; Vllasaliu D
Eur J Pharm Biopharm; 2020 Oct; 155():128-138. PubMed ID: 32853696
[TBL] [Abstract][Full Text] [Related]
3. Recent perspectives on the delivery of biologics to back of the eye.
Joseph M; Trinh HM; Cholkar K; Pal D; Mitra AK
Expert Opin Drug Deliv; 2017 May; 14(5):631-645. PubMed ID: 27573097
[TBL] [Abstract][Full Text] [Related]
4. Oral Delivery of Biologics for Precision Medicine.
Durán-Lobato M; Niu Z; Alonso MJ
Adv Mater; 2020 Apr; 32(13):e1901935. PubMed ID: 31222910
[TBL] [Abstract][Full Text] [Related]
5. Overview and Future Potential of Buccal Mucoadhesive Films as Drug Delivery Systems for Biologics.
Montenegro-Nicolini M; Morales JO
AAPS PharmSciTech; 2017 Jan; 18(1):3-14. PubMed ID: 27084567
[TBL] [Abstract][Full Text] [Related]
6. Strategies and industrial perspectives to improve oral absorption of biological macromolecules.
Liu C; Kou Y; Zhang X; Cheng H; Chen X; Mao S
Expert Opin Drug Deliv; 2018 Mar; 15(3):223-233. PubMed ID: 29111841
[TBL] [Abstract][Full Text] [Related]
7. Advanced formulations for intranasal delivery of biologics.
Rohrer J; Lupo N; Bernkop-Schnürch A
Int J Pharm; 2018 Dec; 553(1-2):8-20. PubMed ID: 30316796
[TBL] [Abstract][Full Text] [Related]
8. Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.
Morales JO; Fathe KR; Brunaugh A; Ferrati S; Li S; Montenegro-Nicolini M; Mousavikhamene Z; McConville JT; Prausnitz MR; Smyth HDC
AAPS J; 2017 May; 19(3):652-668. PubMed ID: 28194704
[TBL] [Abstract][Full Text] [Related]
9. Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases.
Shatz W; Aaronson J; Yohe S; Kelley RF; Kalia YN
Expert Opin Drug Deliv; 2019 Jan; 16(1):43-57. PubMed ID: 30488721
[TBL] [Abstract][Full Text] [Related]
10. Oral Nanomedicine: Challenges and Opportunities.
Deng B; Liu S; Wang Y; Ali B; Kong N; Xie T; Koo S; Ouyang J; Tao W
Adv Mater; 2024 Feb; 36(6):e2306081. PubMed ID: 37724825
[TBL] [Abstract][Full Text] [Related]
11. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
12. Oral inhalation for delivery of proteins and peptides to the lungs.
Fröhlich E; Salar-Behzadi S
Eur J Pharm Biopharm; 2021 Jun; 163():198-211. PubMed ID: 33852968
[TBL] [Abstract][Full Text] [Related]
13. Injectable
Bisht R; Nirmal S; Agrawal R; Jain GK; Nirmal J
J Drug Target; 2021 Jan; 29(1):46-59. PubMed ID: 32729731
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of biologics using drug-device combinations.
Caffarel-Salvador E; Abramson A; Langer R; Traverso G
Curr Opin Pharmacol; 2017 Oct; 36():8-13. PubMed ID: 28779684
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive delivery strategies for biologics.
Anselmo AC; Gokarn Y; Mitragotri S
Nat Rev Drug Discov; 2019 Jan; 18(1):19-40. PubMed ID: 30498202
[TBL] [Abstract][Full Text] [Related]
16. Challenges and strategies for the delivery of biologics to the cornea.
Wels M; Roels D; Raemdonck K; De Smedt SC; Sauvage F
J Control Release; 2021 May; 333():560-578. PubMed ID: 33857565
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers for oral delivery of biologics: small carriers for big payloads.
Cao Y; Rewatkar P; Wang R; Hasnain SZ; Popat A; Kumeria T
Trends Pharmacol Sci; 2021 Nov; 42(11):957-972. PubMed ID: 34593258
[TBL] [Abstract][Full Text] [Related]
18. Introduction for the special issue on recent advances in drug delivery across tissue barriers.
Mrsny RJ; Brayden DJ
Tissue Barriers; 2016; 4(2):e1187981. PubMed ID: 27358759
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous delivery of biotherapeutics: challenges at the injection site.
Sequeira JAD; Santos AC; Serra J; Estevens C; Seiça R; Veiga F; Ribeiro AJ
Expert Opin Drug Deliv; 2019 Feb; 16(2):143-151. PubMed ID: 30632401
[TBL] [Abstract][Full Text] [Related]
20. Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update.
Liu S; Wen X; Zhang X; Mao S
Expert Opin Drug Deliv; 2023; 20(10):1333-1347. PubMed ID: 37439101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
